Literature DB >> 9404727

Neuronal protection from apoptosis by pituitary adenylate cyclase-activating polypeptide.

J Tanaka1, K Koshimura, Y Murakami, M Sohmiya, N Yanaihara, Y Kato.   

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) is known to have trophic effects on neurons. Apoptosis of PC12 cells was induced by depletion of serum and nerve growth factor (NGF) from culture medium. Not only high potassium-induced Ca2+ channel activation but PACAP-38 at physiological concentrations (10[-10] to 10[-8] M) protected PC12 cells from apoptosis. PACAP-38 increased Ca2+ uptake and intracellular Ca2+ concentrations in PC12 cells. The effects of PACAP-38 on cell survival and Ca2+ channels were eliminated by inhibitors for Ca2+ channels and protein kinase A, and mimicked by 8-bromo-cAMP. Mitogen-activated protein (MAP) kinase activity was stimulated by PACAP-38. These findings implicate that PACAP protects PC12 cells from apoptosis by activating Ca2+ channels via the cAMP-protein kinase A pathway to stimulate MAP kinase cascade.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9404727     DOI: 10.1016/s0167-0115(97)01038-0

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  16 in total

1.  Separate cyclic AMP sensors for neuritogenesis, growth arrest, and survival of neuroendocrine cells.

Authors:  Andrew C Emery; Maribeth V Eiden; Lee E Eiden
Journal:  J Biol Chem       Date:  2014-02-24       Impact factor: 5.157

2.  Neuroprotection by endogenous and exogenous PACAP following stroke.

Authors:  Yun Chen; Babru Samal; Carol R Hamelink; Charlie C Xiang; Yong Chen; Mei Chen; David Vaudry; Michael J Brownstein; John M Hallenbeck; Lee E Eiden
Journal:  Regul Pept       Date:  2006-10-04

Review 3.  Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides.

Authors:  Li Shan Chiu; Ryan S Anderton; Neville W Knuckey; Bruno P Meloni
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

4.  Cycloheximide treatment to identify components of the transitional transcriptome in PACAP-induced PC12 cell differentiation.

Authors:  Aurélia Ravni; Lee E Eiden; Hubert Vaudry; Bruno J Gonzalez; David Vaudry
Journal:  J Neurochem       Date:  2006-06-19       Impact factor: 5.372

5.  PACAP38 suppresses cortical damage in mice with traumatic brain injury by enhancing antioxidant activity.

Authors:  Kazuyuki Miyamoto; Tomomi Tsumuraya; Hirokazu Ohtaki; Kenji Dohi; Kazue Satoh; Zhifang Xu; Sachiko Tanaka; Norimitsu Murai; Jun Watanabe; Koichi Sugiyama; Tohru Aruga; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2014-06-08       Impact factor: 3.444

6.  Herpesvirus quiescence in neuronal cells IV: virus activation induced by pituitary adenylate cyclase-activating polypeptide (PACAP) involves the protein kinase A pathway.

Authors:  R J Danaher; A D Savells-Arb; S A Black ; R J Jacob; C S Miller
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

7.  PAC1hop, null and hip receptors mediate differential signaling through cyclic AMP and calcium leading to splice variant-specific gene induction in neural cells.

Authors:  Yvonne Holighaus; Tomris Mustafa; Lee E Eiden
Journal:  Peptides       Date:  2011-06-12       Impact factor: 3.750

8.  STC1 induction by PACAP is mediated through cAMP and ERK1/2 but not PKA in cultured cortical neurons.

Authors:  Yvonne Holighaus; Eberhard Weihe; Lee E Eiden
Journal:  J Mol Neurosci       Date:  2012-01       Impact factor: 3.444

9.  Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) regulate murine neural progenitor cell survival, proliferation, and differentiation.

Authors:  Eugene Scharf; Victor May; Karen M Braas; Kristin C Shutz; Yang Mao-Draayer
Journal:  J Mol Neurosci       Date:  2008-07-15       Impact factor: 3.444

10.  Induction of serpinb1a by PACAP or NGF is required for PC12 cells survival after serum withdrawal.

Authors:  Tommy Seaborn; Aurélia Ravni; Ruby Au; Bill K C Chow; Alain Fournier; Olivier Wurtz; Hubert Vaudry; Lee E Eiden; David Vaudry
Journal:  J Neurochem       Date:  2014-07-10       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.